Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Amgen prepares new agents that inhibit the GCK-GCKR interaction

Sep. 5, 2013

Roche presents novel cathepsin S inhibitors

Sep. 5, 2013

Kyowa Hakko Kirin and Ultragenyx collaborate on development of KRN-23

Sep. 5, 2013

Sanwa Kagaku Kenkyusho announces first launch of topiroxostat in Japan

Sep. 4, 2013

Topline results from phase II ETC-1002 trial reported

Sep. 4, 2013

Merck & Co. discloses new DPP IV inhibitors

Sep. 4, 2013

Takeda Pharmaceutical presents new agents for diabetes

Sep. 4, 2013

Astellas and MSD sign copromotion agreement for ipragliflozin in Japan

Sep. 3, 2013

Research Triangle Institute discloses novel CB1 receptor antagonists

Sep. 2, 2013

AbbVie initiates second pivotal study of elagolix for endometriosis

Aug. 30, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...